|
Study to evaluate clinical consistency of the liquid formulation of GSK Biologicals' HRV vaccine and to evaluate liquid formulation compared to lyophilised formulation of the HRV vaccine administered as a two-dose primary vaccination. |
Rotavirus Vaccine |
107876 |
NCT00382772 2006-003239-61 |
Infections, Rotavirus |
Phase 3 |
|
|
|
|
An annotated case report form is not available for this study. A blank case report form will be provided. |
January 2014 |